the differences between biological and chronological age, with their implications on aml treatment
Published 8 years ago • 2.4K plays • Length 3:07Download video MP4
Download video MP3
Similar videos
-
1:13
cytometry versus morphology in the monitoring of aml
-
5:53
defining therapeutic strategies in elderly acute myeloid leukemia
-
1:41
the future of aml and mds diagnosis and treatment
-
1:15
outcomes of non-intensive chemotherapy differ for idh1 and idh2-mutated aml
-
3:38
genetic ancestry: the implications for biology and prognosis of childhood all
-
2:45
acute myeloid leukemia aml animation
-
13:16
acute lymphoblastic leukemia - all | complete lecture in power point presentation
-
2:32
expert insights: chronological vs. biological aging
-
1:59
novel treatments of aml in elderly patients
-
1:39
germline predisposition to clonal hematopoiesis and its role in leukemia progression
-
1:44
comparison of zuma-1 and scholar-1 outcomes
-
1:46
targeted agents in acute myeloid leukemia in elderly patients
-
4:01
from the bench to bedside: aml treatment
-
1:23
defining elderly patients in the context of dlbcl treatment
-
5:21
examples of biology informing treatment decisions in cll
-
3:59
single-cell transcriptomic analysis of b-all: leukemia cell state and genetic alterations
-
1:40
should amtl be defined as a distinct diagnostic entity?
-
3:25
identifying & monitoring patients with high-risk clonal hematopoiesis
-
1:38
psychological challenges faced by patients with hematological cancers
-
1:39
managing transplant ineligible aml patients
-
1:03
the growing importance of single-cell rna sequencing in hematology